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Genetic Susceptibility Testing and Readiness to Control
Weight: Results from a Randomized Controlled Trial
Susanne F. Meisel1, Rebecca J. Beeken1, Cornelia H. M. van Jaarsveld2, and Jane Wardle1
Objective: To test the hypothesis that adding obesity gene feedback (FTO) to simple weight control advice
at a life stage with raised risk of weight gain (university) increases readiness to control weight.
Methods: Individually randomized controlled trial comparing the effect of: (i) simple weight control advice
plus FTO feedback (FA) and (ii) simple weight control advice only (AO) on readiness to engage with
weight control. Differences in stage of change by genotype and differential weight control behaviors were
secondary outcomes.
Results: Of 1,016 participants randomized, only 279 completed follow-up, yielding 90% power to detect
a small effect for readiness to control weight. As predicted, FA participants were more likely to be in the
contemplation stage than AO participants (P 5 0.023). Participants receiving higher-risk genetic results
were at a higher stage of change than controls (P 5 0.003), with a trend toward a higher stage of change
than those getting lower-risk results (P 5 0.051). Lower-risk results did not decrease weight control inten-
tions compared with controls (P 5 0.55). There were no group differences in adherence to recommended
weight control behaviors (P 5 0.87).
Conclusions: Adding FTO feedback to weight control advice enhanced readiness to control weight, with-
out evidence for genetic determinism, but had no more effect on behavior than weight control advice
alone.
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Introduction
“Personalizing” lifestyle interventions by including information on
genetic risk has been proposed as a novel way to encourage efforts
at obesity prevention (1). Receiving a genetic test result indicative
of increased obesity risk is expected to result in prevention efforts
by increasing risk perceptions, in line with protection motivation
theories (2). However, it has also been argued that genetic infor-
mation could lead to disengagement with health behavior change
(3,4). Receiving a lower-risk result may result in decreased risk
perceptions and thus decreased motivation to prevent obesity. Fur-
thermore, some evidence indicates that genetic information may
lead to fatalism and diminish perceived control over disease devel-
opment (5,6).
Although several studies have examined the psychological
impact of genetic test feedback for risk of obesity in individuals
already struggling with weight control and found it effective for
increasing intentions to lose weight (7-9), a recent Cochrane
review failed to confirm any effect on behavior change (10).
However, most studies in this review focused on gene feedback
to aid smoking cessation. In addition, none has investigated the
effects of genetic test feedback for intentions to prevent weight
gain, although the prevention of ill health is one of the main
expected benefits of returning genetic test feedback to healthy
individuals (1).
One period that has been associated with an increased risk of
weight gain is the transition from high school to university (11,12).
Although anecdotal reports of weight gain of 15 lbs in the first
year of university are prevalent (the so called “Freshman 15”),
empirical evidence indicates that actual weight gain is likely closer
to 5 lbs (13,14). However, because students commonly have low
intentions to implement healthy behaviors (15,16), weight gained
during this period may not be lost over time, leading to an
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increased proportion of young adults classified as overweight or
obese (17).
We were therefore interested in whether genetic feedback for one
gene (FTO) that has been consistently associated with risk of weight
gain (18), would increase readiness to control weight in a population
of first year students, in line with the transtheoretical model of
behavior change (19).
Study objectives
Primary research objective. Evidence from earlier studies on
genetic test feedback indicates that genetic test feedback can
increase behavior change intentions regardless of the “actual”
genetic test result, presumably because of its personalized nature
(20-22). The primary aim of the study was therefore to test the
hypothesis that adding FTO genetic test feedback to simple weight
control advice (Feedback and Advice, FA) would result in greater
readiness to control weight in the intermediate-term (1 month later)
compared with weight control advice alone (Advice only, AO).
Secondary research objectives. All secondary objectives were
exploratory because the trial was not powered to detect significant
differences. There were three secondary objectives.
(i) To examine differences in the effect of FTO feedback on readi-
ness to control weight in normal-weight vs. overweight/obese indi-
viduals. On the basis of previous studies we hypothesized that FTO
feedback would have greater impact in those already overweight or
obese (7-9).
(ii) To examine differences in readiness to control weight in those
receiving higher-risk genetic results, lower-risk results, and no feed-
back. On the basis of previous research using hypothetical scenarios
(21), we hypothesized that a higher-risk result (AA/AT) would result
in greater readiness to control weight than lower-risk (TT) results,
or no genetic feedback (controls). We also explored whether lower-
risk FTO feedback reduced readiness to control weight compared
with not receiving any feedback, to address the concern about
“complacency” raised in the literature (3).
(iii) To explore whether genetic test feedback increased adherence
to weight control advice. We hypothesized that FA participants
would be more likely to adhere to the “tips” included in the weight
control advice than AO participants.
Methods
Study design
The design was a single-center, open, two-arm, parallel group, indi-
vidually randomized (1:1 ratio) controlled trial comparing the effect
of weight control advice plus genetic test feedback (FA) with advice
only (AO), on readiness to control weight (Figure 1). Ethical
approval was granted by the University College London Research
Ethics Committee for non-NHS research in September 2010 (Appli-
cation no: 2471/003).
Participants
A volunteer sample of 1,016 students took part in genetic testing at
baseline. All students aged 18-30 years based at a large London uni-
versity were invited to participate.
Study setting
University College London (UCL) enrolls over 14,000 new under-
graduates each year (mean age at enrolment: 22.8 years, 49% male,
40% international students; http://www.ucl.ac.uk/srs/statistics). Par-
ticipants were recruited using email advertisements in the first 2
weeks of the first term (late September) of three consecutive aca-
demic years (2010-2013). The study ran over the course of the aca-
demic year, with follow-up one month after the intervention group
received the genetic test result (February). Recruitment ended once
the target number of participants was reached.
Interventions
DNA collection and genotyping. Following informed consent,
all participants were asked to give a saliva sample for DNA collec-
tion by placing some sugar onto their tongue to stimulate saliva
flow and then spitting into a plastic tube to generate 1.5-2 ml of
saliva. DNA was extracted and analyzed at the Institute of Meta-
bolic Sciences, Cambridge, UK, as previously published (23).
Weight control leaflet. A weight control leaflet was developed
based on a low-intensity, habit-based, weight-loss intervention that
has shown promising results (24,25). It was divided into three short
sections: The first section outlined why it is easy to gain weight at
university, the second explained the contribution of genes to weight
gain, and the third consisted of seven tips for weight control. Each
tip had a memorable heading followed by a short explanation and
included the following items [watch portion sizes, avoid second
helpings, slow down eating, focus on your food (avoid mindless eat-
ing), pass up snacks between meals, avoid sweet drinks or choose a
“lite” drink, integrate physical activity into every day].
Intervention group (feedback and advice, “FA”
group)
The FA group received the weight control leaflet with their FTO
gene test result four months after baseline data collection. The
genetic test result was given in a letter in an email attachment, so
that students could read it at a convenient time for them. The letter
contained the personal result and brief information about the FTO
gene, its mode of inheritance, and the magnitude of influence on
body weight (7,26).
Control group (advice only, “AO” group)
AO participants received the weight control advice leaflet attached
to an email in identical format to, and at the same time as, the
intervention group. They were informed that they would receive
their FTO genetic test result by the end of the academic year,
resembling a “wait-list control” group for the genetic test feedback
condition.
Measures
Demographic characteristics. Demographic information col-
lected included age and gender.
Primary outcome. Readiness to control weight was assessed
using a validated measure of readiness for behavior change (27)
adapted for prevention of weight gain. Table 1 shows the state-
ments and corresponding stages of change. The time frame was
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adjusted to one rather than six months to reflect the time frame of
the study.
Secondary outcome. Frequency of adherence to each tip was
recorded on a five-point Likert scale, with response options of
“never,” “occasionally,” “sometimes,” “most of the time,” and
“always.”
Sample size
A power calculation conducted a priori using GPower (version 3.1)
showed that a total sample size of 251 would be sufficient to detect
Figure 1 Flowchart study procedures.
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a small effect (d 5 0.25) on motivation to control weight between
“FA” and “AO” with 90% power at the 5% significance level.
Randomization
Data were anonymized using serial numbers immediately after saliva
collection. Participants were randomly assigned following simple ran-
domization procedures to either FA or AO. Group allocation was strati-
fied by data collection wave, before genetic test results became avail-
able. The randomization sequence was generated by SFM using the
“randomize” function of the Statistical Package for Social Sciences
(SPSS) version 20 (Chicago, IL) which randomly assigns a set number
of cases (here: 100%) to a specified number of groups (here: 2), corre-
sponding to a 1:1 allocation ratio of treatment and control group.
Blinding
Participants were not blind to group allocation. However, they were
made aware of group allocation only at the point at which they received
either gene feedback with the advice leaflet or only the advice leaflet,
minimizing the risk of bias. Furthermore, all participants only knew
they were taking part in a study about genes and eating behavior and
that they would be randomized; therefore, self-report responses to the
primary outcome should not have been influenced. The data collector
was unblinded, but questionnaire data (including the primary outcome)
were collected online, and not in the presence of any member of the
research team, to minimize the risk of inadvertent data manipulation.
Finally, because the first author (SFM) acted as both data collector and
data analyst, she was unblinded, but a data analysis plan had been
drawn up prior to data collection, and decisions to change this were
made with the rest of the research team who were blinded, so this
knowledge is unlikely to have affected the final analysis.
Statistical analyses
Analyses were planned to be per protocol (completers only) because
of the anticipated large amount of missing data previously reported
in student samples (11). Analyses were carried out using the Statisti-
cal Package for the Social Sciences SPSS v. 20 (Chicago, IL).
Differences between completers and non-completers on the outcome
measures were assessed with chi-square tests for categorical variables
and independent-samples t tests for continuous variables. As specified
in the study protocol (28), participants who reported having been con-
trolling their weight for more than 1 month were excluded from anal-
yses (n 5 104), because we were interested in the effect of FTO
feedback in individuals who had not yet reached the maintenance
stage of weight control. To assess effects of excluding these partici-
pants we conducted a sensitivity analysis with the full sample. No dif-
ferences in results were observed (data not shown).
For the primary outcome, ordinal logistic regression (Polytomous
Universal Model, PLUM) was used to assess the difference between
“FA” and “AO” group in readiness to control weight. Results from
secondary analyses were considered exploratory. All models
included age, gender and weight status as covariates. Age was
dichotomized into “younger” (18-20 years) and “older” (21) and
weight status into “normal weight” (BMI < 25 kg m22) and
“overweight/obese” (BMI  25 kg m22). Differences in readiness to
control weight by weight status were investigated by including the
group 3 weight status interaction in the ordinal regression model.
To assess the effect of risk status on motivation to control weight
by genotype, FTO status was dichotomized into higher/lower risk,
with those having at least one risk allele being classified as higher
risk in accordance with previous studies (29,30). Ordinal regression
analyses were used to examine effects of risk status on readiness to
control weight by first comparing higher FTO risk and lower risk
with controls and then comparing higher with lower risk. Age, gen-
der, and baseline weight status were included as predictor variables
in all models. To assess group differences in weight control behav-
iors, we built a mean score of the frequency of adherence to the tips
included in the advice. Data were analyzed using ANCOVA includ-
ing age, gender and weight status. Bonferroni corrections for multi-
ple comparisons were used in all analyses, at a 5 0.05.
Results
Participant flow and participant characteristics
Of 1,016 participants taking part at baseline (consenting, completing
BMI measurement, and giving basic demographic information and a
saliva sample for DNA analysis), 77 (7.5%) (intervention: n 5 26;
control n 5 51) were excluded because their genotype could not be
determined (Figure 1). Of the 939 participants invited to complete
the motivation questionnaire 1 month after getting the FTO feedback
(or matched time in controls), 383 (40.7%) completed it, just attain-
ing the expected 40% completion rate. Participants who completed
the questionnaire assessing readiness to control weight (vs. did not)
were likely to be older, t(937) 5 21.99, P 5 0.046) and female
(v2(1) 5 13.25, P < 0.001), and had lower BMI at baseline (t(937)
5 2.77, P 5 0.006). Drop-out was not related to group allocation (P
5 0.317). Participants who reported having controlled their weight
for more than 1 month were excluded from further analyses (27.2%,
n 5 104; FA 5 59, AO 5 45) because they already had reached
the maintenance stage of weight control. These participants were
more likely to be female (v2 (1) 5 9.14, P 5 0.002), with slightly
higher BMI at baseline (t (381) 5 23.29, P 5 0.001), and no dif-
ferences in age. The final sample for analysis of the motivational
effects of genetic test feedback therefore consisted of 279 partici-
pants. Participant characteristics for each randomized group are
shown in Table 2, and by genotype in Table 3.
Primary outcome: Readiness to control weight at
follow-up
Participants in the FA group were significantly more likely to be in
the contemplation stage (thinking about controlling their weight) or
the action stage (having started to control weight) than those in the
TABLE 1 Stages of change and corresponding statements
Stage of change Questionnaire item
Precontemplation I am not trying to control my weight, and I have
no intention of doing so in the next month
Contemplation/
preparation
I am not trying to control my weight, but I am
thinking of doing something in the next month
Action I started to try to control my weight within
the last month
Maintenance I have been trying to control my weight for
more than a month
Obesity Effects of Genetic Testing for Weight Control Meisel et al.
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control group (OR 5 1.77, 95% CI 5 1.08-2.89, P 5 0.023) (see
Table 4), although the mean scores in both groups indicated low
motivation overall (FA: 1.6, SD 5 0.8; AO: 1.5, SD 5 0.8).
Secondary outcomes
Effects of the intervention in subgroups at follow-up. Women
were more likely to be in the contemplation stage than men (OR 5
2.91, 95% CI 5 1.76-4.81, P < 0.001). Overweight/obese participants
were also more likely to be in the contemplation stage than those of
normal weight (OR 5 4.80, 95% CI 5 2.13-10.77, P < 0.001).
As shown in Figure 2, the group 3 weight status interaction was
significant, with overweight/obese individuals in the FA group being
more likely to be in the contemplation stage or the action stage at 1-
month follow-up than normal-weight individuals in the FA group
(OR 5 6.67, 95% CI 5 1.13-39.25, P 5 0.036).
Effect of FTO risk status on readiness to control weight at
follow-up. The FTO genotype was in Hardy–Weinberg equilib-
rium in the current sample (v2 (2) 5 5.68; P 5 0.058). Nineteen
(13.7%) participants had the higher-risk AA genotype, 55 (39.6%)
had the intermediate risk AT genotype and 65 (46.8%) had the
lower-risk TT genotype.
As shown in Figure 3, there was a significant effect of FTO status
on readiness to control weight at 1-month follow-up, with higher-
risk participants being more likely to be in the contemplation stage
than control participants who were in the precontemplation stage
and had no weight control intentions (OR 5 2.38, 95%CI 5 1.33-
4.26, P 5 0.003). There was also a trend for higher risk (AT/AA)
participants to be more likely to be in the contemplation stage than
lower-risk (TT) participants who were in the precontemplation stage
(OR 5 1.97, 95%CI 5 1.00-3.88, P 5 0.052). There was no signifi-
cant difference in readiness to control weight between lower-risk
(TT) participants and those in the control group (P 5 0.546), as
shown in Table 5.
Behavior change. A factor analysis confirmed that the individual
items in the composite scale shared a common underlying structure
(Crohnbach’s a 5 0.72). The overall number of tips followed was
low (1.42, SD 5 1.7), reflecting “occasional” use of weight control
behaviors, and there was no significant difference in frequency
between groups (P 5 0.874). Age, gender and weight status also
showed no association with the number of tips followed.
Potential harms
We were not made aware of any harm caused by the intervention.
In fact, participants made many positive comments, suggesting that
both weight control advice and the genetic test feedback were well
received.
Discussion
This is the first study to investigate the utility of FTO genetic test
feedback to motivate young, healthy individuals with weight control.
In line with our hypothesis, weight control advice in conjunction
with FTO feedback successfully increased motivation more than
weight control advice alone, and effects were stronger in those
receiving a higher-risk result. Importantly, lower-risk FTO feedback
did not decrease motivation to engage with weight control, with
effects being equivalent to receiving no genetic test feedback. This
finding matches those from the smoking cessation field (31,32) and
hints that complacency to lower-risk genetic test feedback for
weight gain prevention may not be as much of a concern as has
TABLE 2 Participant characteristics at follow-up
Intervention
(feedback
and advice,
n 5 139)
Control
(advice onl-
y, n 5 140)
Gender, male % (n) 51.1 (71) 47.9 (67)
Age in years mean (SD) 20.2 (2.5) 20.9 (3.0)
Height in m, mean (SD) 1.70 (0.1) 1.70 (0.1)
Weight in kg, mean (SD) 62.3 (10.8) 63.0 (11.7)
BMI in kg m22, mean (SD) 21.2 (2.5) 21.4 (2.6)
Normal weight, % (n) <25 92.1 (128) 89.3 (125)
Overweight/obese, % (n) 25 7.9 (11) 10.7 (15)
FTO status, % (n)
AA 13.7 (19) - -
AT 39.6 (55) - -
TT 46.8 (65) - -
BMI: body mass index; TT: lower-risk FTO gene status; AT, AA: higher-risk FTO
gene status.
TABLE 3 Participant characteristics at follow-up by genotype
Control TT AT/AA
Gender, male % (n) 47.9 (67) 47.7 (31) 54.1 (40)
Age in years mean (SD) 20.9 (3.1) 20.2 (2.7) 20.2 (2.7)
Height in m, mean (SD) 1.70 (0.09) 1.70 (0.1) 1.71 (0.09)
Weight in kg, mean (SD) 63.0 (11.7) 60.5 (11.8) 63.8 (11.8)
BMI in kg m22, mean (SD) 21.5 (2.6) 20.7 (2.4) 21.7 (2.7)
Normal weight, % (n) <25 89.3 (125) 95.4 (62) 89.2 (66)
Overweight/obese, % (n) 25 10.7 (15) 4.6 (3) 10.8 (8)
BMI: body mass index; TT: lower-risk FTO gene status; AT, AA: higher-risk FTO gene status
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been thought. One reason may be that individuals may hold multi-
faceted causal explanations of weight gain, including both genetics
and environmental factors (33), which may diminish any adverse
impact of the genetic test result.
Genetic test feedback appeared to be especially effective in increas-
ing readiness to prevent weight gain for individuals who were
already overweight, perhaps because of greater perceived relevance
of the test result. Alternatively, it is possible that genetic test feed-
back reduces self-blame and stigma, which has been posited as a
barrier to weight control (7,26). Given that individuals did not enroll
specifically in a weight control intervention, this is encouraging.
However, the results have to be viewed with caution because only a
small number of overweight/obese individuals returned for follow-
up. Equally, although the intervention achieved modest effects on
readiness to control weight, contrary to our secondary hypothesis,
this did not translate into action, regardless of the gene test status.
However, the results might plant a seed that could have effects in
the future (e.g., if they gain weight). Long-term studies on the
effects of genetic test feedback for common conditions are needed
in this new field of research.
These findings add to the emerging literature on the effects of
genetic test feedback as an aid for prevention and control of com-
mon, complex disorders. In contrast to earlier work focused on
improving treatment adherence (34), the focus on prevention of
weight gain in a community sample of young, healthy adults at
TABLE 4 Ordinal logistic regression (PLUM) for the effect of the intervention (FA vs. AO) on readiness to control weight
Predictor variable
Multivariate model
Multivariate model including
interaction terms
OR 95% CI P value OR 95% CI P value
Gender
Male 1 1
Female 2.91 1.76-4.81 <0.001 2.98 1.79-4.95 <0.001
Age
18-20 1 1
21-30 0.87 0.53-1.44 0.594 0.89 0.53-1.48 0.646
Weight status
BMI < 25 1 1
BMI  25 4.80 2.14-10.77 <0.001 2.32 0.79-6.83 0.127
Group
AO 1 1
FA 1.77 1.08-2.89 0.023 1.46 0.87-2.45 0.127
Intervention group 3 BMI < 25 1
Intervention group 3 BMI  25 - - - 6.67 1.13-39.25 0.036
BMI: body mass index; FA: feedback and advice group; AO: advice only
Figure 2 Effect of FTO genetic feedback on readiness to control weight in
subgroups. Figure 3 Readiness to control weight by FTO status.
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university is novel. However, despite differences in context, our
findings match earlier studies (10,22,32,34) in finding that genetic
test feedback can affect behavior change intentions, shows no
obvious adverse psychological effects, but has little or no effect on
actual behavior change.
This study had a number of strengths. Despite high drop-out rates, it
is one of the first trials to be powered to detect an effect of genetic
test feedback on the outcome of interest. The study set-up provided
a model for a possible “real world” scenario should genetic test
feedback be introduced on a large scale to aid disease prevention,
i.e., we chose a young, healthy population largely unaware of their
genetic risk. The intervention could also be administered to a large
sample without specific training, in a cost-effective manner (gene
testing was priced at 1.50 pounds sterling per analysis), and without
extensive staff resources.
It also had important limitations. Baseline weight control intentions
were not assessed, so that no direct evidence of change in motiva-
tion as a result of genetic test feedback is available, only a between-
group comparison (although groups were randomized). Although
readiness to control weight was assessed with an established mea-
sure of stage of change, it comprised only a single item, which lim-
its robustness of the findings. Future studies could explore the topic
using more straightforward measures of motivation. Furthermore,
since we were interested in the effect of FTO feedback on initiation
of weight control, we had to exclude about a quarter of participants
due to the chosen measure, although the sensitivity analysis indi-
cated that effects were not significantly different when all partici-
pants were included. In addition, although the weight control leaflet
was evidence-based, it had not been piloted specifically in the pre-
vention context. The absence of a “no treatment” control group pre-
cluded any conclusion on whether the leaflet alone would be effec-
tive in behavior change, but that was not the focus of the study.
Participants were not specifically encouraged to follow the tips in
the leaflet because we were interested in whether genetic test feed-
back would be a sufficient prompt for initiating action without addi-
tional support. They may have engaged in alternative weight control
behaviors not mentioned in the tips, but these were not assessed.
Finally, the study suffered from high drop-out rates. Although this
was anticipated, it nonetheless limits the generalizability of findings.
Participants were more likely to enroll if they were normal weight
and less likely to return for follow-up if they had a higher BMI at
baseline, which limited opportunities for exploring effects of FTO
test feedback in individuals who were already overweight.
Conclusion
This study provides evidence that FTO genetic test feedback can
successfully increase readiness to control weight in a young, healthy
population in a situation with established risk of weight gain, but it
found no evidence that it impacted actual behavior. However,
importantly, it did not lessen weight control intentions or behaviors,
suggesting that concerns about genetic determinism leading to disen-
gagement from behavior change following obesity genetic testing
may be unfounded.O
Acknowledgments
The authors thank David Withers (Cambridge University, Institute
of Metabolic Sciences, Cambridge, UK) for performing the DNA
analysis.
VC 2014 The Authors Obesity published by Wiley Periodicals, Inc. on
behalf of The Obesity Society (TOS)
References
1. Collins F. Has the revolution arrived? Nature 2010;464:674-675.
2. Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the health
belief model. Health Educ 1988;15:175–183.
3. Marteau TM, Weinman J. Self-regulation and the behavioural response to DNA risk
information: a theoretical analysis and framework for future research. Soc Sci Med
2006;62:1360-1368.
4. Haga SB, Khoury MJ, Burke W. Genomic profiling to promote a healthy lifestyle:
not ready for prime time. Nat Genet 2003;34:347-350.
5. Shiloh S, Rashuk-Rosenthal D, Benyamini Y. Illness causal attributions: an
exploratory study of their structure and associations with other illness cognitions
and perceptions of control. J Behav Med 2002;25:373-394.
6. Senior V, Marteau TM, Peters TJ. Will genetic testing for predisposition for disease
result in fatalism?. A qualitative study of parents responses to neonatal screening
for familial hypercholesterolaemia. Soc Sci Med 1999;48:1857-1860.
7. Meisel SF, Wardle J. Responses to FTO genetic test feedback for obesity in a
sample of overweight adults: a qualitative analysis. Genes Nutr 2014;9:374.
8. Conradt M, Dierk JM, Schlumberger P, et al. A consultation with genetic
information about obesity decreases self-blame about eating and leads to realistic
weight loss goals in obese individuals. J Psychosom Res 2009;66:287-295.
9. Harvey-Berino J, Gold EC, West DS, et al. Does genetic testing for obesity
influence confidence in the ability to lose weight?. A pilot investigation. J Am Diet
Assoc 2001;101:1351-1353.
10. Marteau TM, French DP, Griffin SJ, et al. Effects of communicating DNA-based
disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev
2010;10:CD007275.
11. Serlachius A, Hamer M, Wardle J. Stress and weight change in university students
in the United Kingdom. Physiol Behav 2007;92:548-553.
12. Anderson DA, Shapiro JR, Lundgren JD. The Freshman year of college as a critical
period for weight gain: an initial evaluation. Eat Behav 2003;4:363-367.
TABLE 5 Ordinal regression analysis (PLUM) for the effect of
FTO status (control vs. TT vs. AT/AA) on readiness to
control weight
Predictor variable OR 95% CI P value
Gender
Male 1
Female 3.15 1.88-5.28 <0.001
Age group
18-20 1
21-30 0.96 0.39-2.36 0.360
Weight status
BMI < 25 1
BMI  25 4.90 2.17-11.07 <0.001
FTO feedback
Control 1
TT 1.21 0.65-2.27 0.546
AT, AA 2.38 1.33-4.26 0.003
FTO feedback
TT 1
Control 0.82 0.44-1.54 0.546
AT, AA 1.97 1.00-3.88 0.051
BMI: body mass index; TT: lower-risk FTO gene status; AT, AA: higher-risk FTO
gene status.
Original Article Obesity
CLINICAL TRIALS: BEHAVIOR, PHARMACOTHERAPY, DEVICES, SURGERY
www.obesityjournal.org Obesity | VOLUME 23 | NUMBER 2 | FEBRUARY 2015 311
13. Mihalopoulos NL, Auinger P, Klein JD. The Freshman 15: is it real? J Am Coll
Health 2008;56:531-534.
14. Hoffman DJ, Policastro P, Quick V, Lee SK. Changes in body weight and fat mass
of men and women in the first year of college: a study of the “Freshman 15.” J Am
Coll Health 2006;55:41-46.
15. Steptoe A, Wardle J. Health behaviour, risk awareness and emotional well-being in
students from Eastern Europe and Western Europe. Soc Sci Med 2001;53:1621-1630.
16. Steptoe A, Wardle J, Cui W, et al. Trends in smoking, diet, physical exercise, and
attitudes toward health in European university students from 13 countries, 1990-
2000. Prev Med 2002;35:97-104.
17. Lewis CE, Jacobs DR, McCreath H, et al. Weight gain continues in the 1990s: 10-
year trends in weight and overweight from the CARDIA study. Am J Epidemiol
2000;151:1172-1181.
18. Frayling TM, Timpson NJ, Weedon MN, et al. A common variant in the FTO gene
is associated with body mass index and predisposes to childhood and adult obesity.
Science 2007;316:889-894.
19. Prochaska JO, DiClemente C. The Transtheoretical Approach: Crossing Traditional
Boundaries of Change, Malabar, FL: Krieger; 1984.
20. Sanderson SC, O’Neill SC, White DB, et al. Responses to online GSTM1 genetic
test results among smokers related to patients with lung cancer: a pilot study.
Cancer Epidemiol Biomarkers Prev 2009;18:1953-1961.
21. Meisel SF, Walker C, Wardle J. Psychological responses to genetic testing for
weight gain: a vignette study. Obesity 2012;20:540-546.
22. Bloss CS, Schork NJ, Topol EJ. Effect of direct-to-consumer genomewide profiling
to assess disease risk. N Engl J Med 2011;364:524-534.
23. Wardle J, Carnell S, Haworth CM, Farooqi IS, O’Rahilly S, Plomin R. Obesity
associated genetic variation in FTO is associated with diminished satiety. J Clin
Endocrinol Metab 2008;93:3640-3643.
24. Beeken RJ, Croker H, Morris S, et al. Study protocol for the 10 top tips (10TT)
trial: randomised controlled trial of habit-based advice for weight control in general
practice. BMC Public Health 2012;12:667.
25. Lally P, Chipperfield A, Wardle J. Healthy habits: efficacy of simple advice on
weight control based on a habit-formation model. Int J Obes 2008;32:700-707.
26. Meisel SF, Wardle J. “Battling my biology”: psychological effects of genetic testing
for risk of weight gain. J Gen Counsel 2013;23:179-186.
27. Sarkin JA, Johnson SS, Prochaska JO, Prochaska JM. Applying the transtheoretical
model to regular moderate exercise in an overweight population: validation of a
stages of change measure. Prev Med 2001;33:462-469.
28. Meisel S, Beeken R, van Jaarsveld C, Wardle J. Genetic test feedback with
weight control advice: study protocol for a randomized controlled trial. Trials 2012;
13:235.
29. Dougkas A, Yaqoob P, Givens DI, Reynolds CK, Minihane AM. The impact of
obesity-related SNP on appetite and energy intake. Br J Nutr 2013;110:1151-1156.
30. den Hoed M, Westerterp-Plantenga MS, Bouwman FG, Mariman EC, Westerterp
KR. Postprandial responses in hunger and satiety are associated with the rs9939609
single nucleotide polymorphism in FTO. Am J Clin Nutr 2009;90:1426-1432.
31. Audrain J, Boyd NR, Roth J, Main D, Caporaso NE, Lerman C. Genetic
susceptibility testing in smoking-cessation treatment: one-year outcomes of a
randomized trial. Addict Behav 1997;22:741-751.
32. Hollands GJ, Sophia CLW, Richard AP, et al. Effect of communicating DNA based
risk assessments for Crohn’s disease on smoking cessation: randomised controlled
trial. BMJ 2012;345:e4708.
33. Wang C, Coups E. Causal beliefs about obesity and associated health behaviors:
results from a population-based survey. Int J Behav Nutr Phys Act 2010;7:19.
34. Grant RW, O’Brien KE, Waxler JL, et al. Personalized genetic risk counseling to
motivate diabetes prevention: a randomized trial. Diabetes Care 2013;36:13-19.
Obesity Effects of Genetic Testing for Weight Control Meisel et al.
312 Obesity | VOLUME 23 | NUMBER 2 | FEBRUARY 2015 www.obesityjournal.org
